Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Mycotopia Therapies, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2,183 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.87M | $12.82M |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | +16.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $61,217 | $1,000 | $249 | $0 | $323 | $672 | $14.52M | $12.53M |
| Gross Profit? | $2,183 | $0 | -$61,217 | -$1,000 | -$248 | $0 | -$323 | -$672 | $349,806 | $284,100 |
| Gross Margin? | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +2.4% | +2.2% |
| Operating Expenses? | $1.85M | $1.63M | $555,507 | $1.74M | $4.99M | $159,449 | $251,718 | $186,074 | $174,561 | $194,117 |
| Operating Income? | -$1.84M | -$1.63M | -$616,724 | -$1.74M | -$4.99M | -$159,449 | -$251,718 | -$186,074 | $175,240 | $89,980 |
| EBITDA? | -$1.84M | -$1.63M | -$555,507 | -$1.74M | -$4.99M | -$13,675 | -$252,892 | -$169,484 | $205,504 | $110,597 |
| Income Before Tax | -$2.22M | -$1.85M | -$1.18M | -$2.61M | -$5.14M | -$157,235 | -$253,222 | -$170,275 | $204,589 | $109,223 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $84,970 | $0 | $0 | $74,769 | $36,869 |
| Net Income? | -$2.22M | -$1.85M | -$1.18M | -$2.61M | -$5.14M | -$242,205 | -$17,456 | $61,202 | $129,819 | $72,354 |
| EPS? | $0.00 | $-0.14 | $-0.08 | $-0.18 | $-0.38 | $-0.02 | $-0.00 | $0.00 | $0.01 | $0.01 |
| Diluted EPS? | $0.00 | $-0.14 | $-0.08 | $-0.18 | $-0.38 | $-0.02 | $-0.00 | $0.00 | $0.01 | $0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality